Twist Bioscience Corporation (TWST) Q1 2019 Earnings Results

Twist Bioscience Misses on EPS, Stock Down 4.78%

The earnings report indicates that Twist Bioscience is facing challenges, as reflected in the missed EPS figure. The stock reacted negatively, dropping 4.78%, likely due to the lack of revenue data and guidance. Investors may be concerned about the company's short-term performance and future prospects without clear direction from management.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-1.18	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed a cautious outlook, emphasizing the importance of long-term strategy over immediate financial results. They did not provide specific guidance, reflecting uncertainty in the market.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on long-term growth despite current challenges.

Twist Bioscience Misses on EPS, Stock Down 4.78%

Key numbers

Management commentary

Twist Bioscience Corporation

More earnings this week

Twist Bioscience Misses on EPS, Stock Down 4.78%

Key numbers

Management commentary